Becro Ltd. (Greece)

BECRO (Becro Ltd.) is an independent contract research organization (CRO) based in Greece, with offices in Athens and Larissa as well as Nicosia, Cyprus. The company positions itself as a specialist in clinical trial and study services for generic pharmaceutical products and medical devices, offering start-to-finish support that runs from study set-up through to regulatory submission. Its stated client base is pharmaceutical and medical device companies, and its service model is built around a set of Standard Operating Procedures (SOPs) that govern the organization's work. BECRO was founded by professionals with backgrounds in regulatory agencies, the pharmaceutical industry and academia, giving the organization what it describes as broad experience and insight in drug development and regulation. The company operates according to Good Clinical Practice (GCP) and ICH guidelines, the Declaration of Helsinki, and the applicable regulatory and ethical rules governing research involving human subjects. Its affiliated bioanalytical laboratory is GLP certified, and BECRO itself has been inspected by the US FDA with a positive outcome, with the inspection finding no regulatory violations. BECRO has also been approved by the Hellenic Organization for Medicines (EOF), a member of the EMA, to conduct clinical trials, and holds EOF registration number 118-C-17. Geographically, BECRO operates in Greece and Cyprus, both European Union member states, and all of its activities are subject to inspection by European and national regulatory authorities. The company highlights the advantages of running studies in Greece, including an average study approval time of roughly one month, regulatory compliance with EMA/FDA/ICH requirements, fast patient recruitment, cost savings relative to trials in the United States and Western/Northern Europe, and access to experienced, GCP-qualified investigators at clinical centers. As an example of recruitment speed, BECRO cites a therapeutic equivalence study for latanoprost involving 200 patients that completed recruitment in three months. BECRO's therapeutic coverage is supported by a panel of medical advisors spanning haematology, oncology, cardiovascular disease and hypertension, nephrology, autoimmune and rheumatological diseases, pulmonary diseases, metabolic disorders including diabetes mellitus and osteoporosis, neurology, gynaecology, otorhinolaryngology, orthopedics, dermatology and ophthalmology. The company's core offering is clinical and bioequivalence studies conducted on behalf of sponsors, with a particular emphasis on generic products and medical devices.

BECRO is an independent contract research organization (CRO) based in Greece. It was founded by professionals drawn from regulatory agencies, the pharmaceutical industry and academia, a founding composition the company presents as the basis of its expertise in drug development and regulation. The organization operates from Greece, with locations in Athens and Larissa, and from Cyprus, with a location in Nicosia; both countries are European Union members, and BECRO states that all of its activities are subject to inspection by European and national regulatory authorities. BECRO's service model is built around clinical trial and study services for generic pharmaceutical products and medical devices, covering the process from study set-up through to submission. The company works according to Good Clinical Practice (GCP) and ICH guidelines, the Declaration of Helsinki, and the regulatory and ethical legislation applicable whenever human subjects are involved. Its affiliated bioanalytical laboratory is GLP certified. BECRO has been approved by the Hellenic Organization for Medicines (EOF), a member of the EMA, to conduct clinical trials, and holds EOF registration number 118-C-17. The company has also been inspected by the US FDA, with the inspection outcome reported as positive and no regulatory violations found. In describing the rationale for conducting studies in Greece, BECRO cites an average study approval time of approximately one month, compliance with EMA/FDA/ICH regulations, fast recruitment rates, cost savings compared with trials in the United States and Western/Northern Europe, and access to clinical centers whose investigators are GCP qualified and experienced in conducting clinical trials. As an illustration of recruitment speed, the company cites a therapeutic equivalence study for latanoprost with 200 patients in which recruitment lasted three months. BECRO's therapeutic scope is supported by a panel of medical advisors covering haematology, oncology, cardiovascular diseases and hypertension, nephrology, autoimmune diseases and rheumatology, pulmonary diseases, metabolic disorders including diabetes mellitus and osteoporosis, neurology, gynaecology, otorhinolaryngology, orthopedics, dermatology and ophthalmology. The company's stated mission is to provide high-quality services to pharmaceutical and medical device companies, and it emphasizes that all services follow a set of Standard Operating Procedures embraced across the organization.

• BECRO is approved by the Hellenic Organization for Medicines (EOF), a member of the EMA, to conduct clinical trials; EOF registration number 118-C-17.

• BECRO is inspected by the US FDA, with the inspection outcome reported as positive and no regulatory violations found.

• BECRO's affiliated bioanalytical laboratory is GLP certified.

Independent CRO specializing in clinical trial and bioequivalence services for generic pharmaceutical products and medical devices, operating in Greece and Cyprus within the EU regulatory framework.

• Clinical trial services for generics

  End-to-end clinical trial services for generic pharmaceutical products, from study set-up to submission.

• Bioequivalence studies

  Bioequivalence studies conducted on behalf of pharmaceutical sponsors.

• Therapeutic equivalence studies

  Therapeutic equivalence studies, such as the cited latanoprost study with 200 patients.

• Medical device clinical studies

  Clinical study services for medical device companies.

1. 1BECRO CRO - Contract Services Organization - Clinical Trialsbecro.gr
2. 2Introduction - BECRO - CRO Greece - Contract Services Organization - Clinical Trials - Bioequivalence Studies - Therapeutic Equivalence - Medical Devicesbecro.gr
3. 3Becro Ltd. (Greece) - Wikidatawikidata.org